Dr. Tenold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Mowry Ave
Fremont, CA 94538Phone+1 510-797-1111
Education & Training
University of California DavisChief Fellow, Hematology & Oncology, 2020 - 2021
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2018 - 2021- University of California Davis HealthResidency, Internal Medicine, 2015 - 2021
Albany Medical CollegeClass of 2015
Certifications & Licensure
CA State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Member Gold Humanism Honor Society, 2015
- Kenneth B Olsen Prize Albany Medical College, 2015
Publications & Presentations
PubMed
- 3 citationsClinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehen...Tamer Othman, Benjamin N Moskoff, Gwendolyn Ho, Matthew E Tenold, Tali Azenkot
Leukemia Research. 2022-08-01 - Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center.Matthew E. Tenold, Benjamin N Moskoff, Rajeev Krishnan, Aaron S. Rosenberg, Rasmus T. Hoeg
Clinical Lymphoma, Myeloma & Leukemia. 2021-07-01 - 2 citationsAn evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.Tamer Othman, Matthew E. Tenold, Benjamin N Moskoff, Tali Azenkot, Brian A. Jonas
Expert Review of Hematology. 2021-06-15
Books/Book Chapters
Abstracts/Posters
- Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer CenterMatthew Tenold, MD BS, Benjamin Moskoff, PharmD, David Benjamin, MD, Brian A. Jonas, MD PhD, American Society of Hematology, San Diego, 11/29/2018
- Retrospective Analysis of Adult Relapsed and Refractory Acute Leukemia Patients Treated with FLAG at a Comprehensive Cancer CenteMatthew Tenold, MD, Benjamin Moskoff, PharmD, Rajeev Krishnan, MD, Aaron Seth Rosenberg, MD, Brian A Jonas, MD PhD, American Society of Hematology, Atlanta, GA, 12/7/2017
Press Mentions
Primo Lara, MD, and Matthew Tenold, MD, on Treating Advanced Renal Cell CancerNovember 5th, 2020
Professional Memberships
- Member
- Member
External Links
- UCSFhttps://www.ucsfhealth.org/providers/dr-matthew-tenold
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
